Vivorte has two innovative orthopedic technologies in their pipeline. The first a combination synthetic/biologic bone void filler has received FDA clearance.
Vivorte's mission is to identify, develop and commercialize orthopedic devices which address unmet needs in markets exceeding $1B. We have 2 products: a minimally invasive implantable device designed to treat osteoporosis & hip fractures and a synthetic/biologic bone void filler (BVF) which is both strong and remodels. We have achieved revenue with the BVF and are discussing a distribution/licensing deal with an established company.